Balentine LLC Organon & Co. Transaction History

Balentine LLC

  • $2.54 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 26, 2022
BUY
$31.66 - $38.9 $211,013 - $259,268
6,665 Added 55.18%
18,744 $633,000
Q2 2022

Aug 15, 2022
BUY
$31.66 - $38.9 $211,013 - $259,268
6,665 Added 55.18%
18,744 $633,000
Q1 2022

Oct 26, 2022
SELL
$30.45 - $39.36 $202,949 - $262,334
-6,665 Reduced 35.56%
12,079 $422,000
Q1 2022

May 06, 2022
BUY
$30.45 - $39.36 $367,805 - $475,429
12,079 New
12,079 $422,000

Others Institutions Holding OGN

# of Institutions
791
Shares Held
193M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email